BACKGROUND: Atrial fibrillation (AF) is a common arrhythmia with relevant impact on mortality and morbidity. Pulmonary vein isolation (PVI) is an established therapy in patients who remain symptomatic under optimal medical therapy. However, up to 70% of patients present with recurrence of AF after PVI. Therefore, identifying ideal candidates is an unmet clinical need. Left atrial (LA) fibrosis is associated with reduced LA function. Analysis of LA mechanics using 2D speckle tracking echocardiography (STE) might give more insight into LA substrates and be therefore of predictive value. METHODS: This prospective single-center pilot study included 31 patients (mean age, 62.3 ± 9.1 years; 19 males) with AF who underwent PVI and 20 matched healthy controls (mean age, 60.6 ± 6.6 years; 10 males). 2D STE strain indices of LA reservoir (RLA), conduit, and, if feasible, contractile function, were analyzed before and 6 months after PVI. Assessment of the LV diastolic function was based on standard indices. Responders to PVI were defined as being asymptomatic and free of AF in a 7-day Holter-ECG after 6 months. RESULTS: At baseline, all patients with AF had significantly lower reservoir and contractile function compared with controls. After 6 months, 17 patients (54.8%) were identified as responders. At baseline, the reservoir function was significantly higher in responders compared with nonresponders (32.7 ± 11.1 vs. 22.9 ± 10.9%; P = 0.019). Only in responders, RLA and contractile LA function improved and reached normal values whereas LA function remained unchanged in nonresponders. In a ROC analysis, a RLA value of ≥19.5% discriminated responders and nonresponders in patients with persistent AF with a sensitivity of 86% and a specificity of 100% (P = 0.012; area under the curve 0.943; CI, 0.81-1.0). CONCLUSIONS: LA reservoir function helps to predict efficacy of PVI after 6 months. Only in responders, reservoir, and contractile function normalized within 6 months after PVI indicating a lower level of atrial remodeling at baseline. No deleterious effects of ablation were detected in nonresponders.
BACKGROUND:Atrial fibrillation (AF) is a common arrhythmia with relevant impact on mortality and morbidity. Pulmonary vein isolation (PVI) is an established therapy in patients who remain symptomatic under optimal medical therapy. However, up to 70% of patients present with recurrence of AF after PVI. Therefore, identifying ideal candidates is an unmet clinical need. Left atrial (LA) fibrosis is associated with reduced LA function. Analysis of LA mechanics using 2D speckle tracking echocardiography (STE) might give more insight into LA substrates and be therefore of predictive value. METHODS: This prospective single-center pilot study included 31 patients (mean age, 62.3 ± 9.1 years; 19 males) with AF who underwent PVI and 20 matched healthy controls (mean age, 60.6 ± 6.6 years; 10 males). 2D STE strain indices of LA reservoir (RLA), conduit, and, if feasible, contractile function, were analyzed before and 6 months after PVI. Assessment of the LV diastolic function was based on standard indices. Responders to PVI were defined as being asymptomatic and free of AF in a 7-day Holter-ECG after 6 months. RESULTS: At baseline, all patients with AF had significantly lower reservoir and contractile function compared with controls. After 6 months, 17 patients (54.8%) were identified as responders. At baseline, the reservoir function was significantly higher in responders compared with nonresponders (32.7 ± 11.1 vs. 22.9 ± 10.9%; P = 0.019). Only in responders, RLA and contractile LA function improved and reached normal values whereas LA function remained unchanged in nonresponders. In a ROC analysis, a RLA value of ≥19.5% discriminated responders and nonresponders in patients with persistent AF with a sensitivity of 86% and a specificity of 100% (P = 0.012; area under the curve 0.943; CI, 0.81-1.0). CONCLUSIONS: LA reservoir function helps to predict efficacy of PVI after 6 months. Only in responders, reservoir, and contractile function normalized within 6 months after PVI indicating a lower level of atrial remodeling at baseline. No deleterious effects of ablation were detected in nonresponders.
Authors: Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista Journal: J Am Soc Echocardiogr Date: 2009-02 Impact factor: 5.251
Authors: A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof Journal: Europace Date: 2012-08-24 Impact factor: 5.214
Authors: D Katritsis; M Hossein-Nia; A Anastasakis; I Poloniecki; D W Holt; A J Camm; D E Ward; E Rowland Journal: Eur Heart J Date: 1997-06 Impact factor: 29.983
Authors: Atul Verma; Fethi Kilicaslan; James R Adams; Steven Hao; Salwa Beheiry; Stephen Minor; Volkan Ozduran; Samy Claude Elayi; David O Martin; Robert A Schweikert; Walid Saliba; James D Thomas; Mario Garcia; Allan Klein; Andrea Natale Journal: J Cardiovasc Electrophysiol Date: 2006-07
Authors: Geoffrey Lee; Paul B Sparks; Joseph B Morton; Peter M Kistler; Jitendra K Vohra; Caroline Medi; Raphael Rosso; Andrew Teh; Karen Halloran; Jonathan M Kalman Journal: J Cardiovasc Electrophysiol Date: 2010-08-19
Authors: Suman S Kuppahally; Nazem Akoum; Nathan S Burgon; Troy J Badger; Eugene G Kholmovski; Sathya Vijayakumar; Swati N Rao; Joshua Blauer; Eric N Fish; Edward V R Dibella; Rob S Macleod; Christopher McGann; Sheldon E Litwin; Nassir F Marrouche Journal: Circ Cardiovasc Imaging Date: 2010-02-04 Impact factor: 7.792
Authors: Roman Leischik; Henning Littwitz; Birgit Dworrak; Pankaj Garg; Meihua Zhu; David J Sahn; Marc Horlitz Journal: Biomed Res Int Date: 2015-07-07 Impact factor: 3.411